MedTrace Logo

Towards Detecting Cocaine Use Using Smartwatches in the NIDA Clinical Trials Network

NCT02915341 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2018-07-18

No results posted yet for this study

Summary

The overall objective of this study is to extend previous work in the development of methods to automatically detect the timing of cocaine use from cardiac interbeat interval and physical activity data derived from wearable, unobtrusive mobile sensor technologies. The specific objectives of this protocol are to characterize under which conditions high quality continuous interbeat interval data and physical activity data can be obtained from a specially developed smartwatch device in the natural field setting among a population of cocaine users. In addition to identifying common failure scenarios and understanding wearability/usage patterns when collecting interbeat interval from smartwatches, this study will extend previous work in the detection of cocaine use via interbeat interval and physical activity data that were previously obtained from wearable chestband sensors. Information from this study will contribute toward the adaptation of the investigators' existing computational model for detecting cocaine use via the chest sensors, so it can be applied to the interbeat and physical activity data obtained from less obtrusive smartwatches.

Conditions

  • Cocaine-Related Disorders

Sponsors & Collaborators

  • National Drug Abuse Treatment Clinical Trials Network

    collaborator NETWORK

  • University of Memphis

    collaborator OTHER

  • Johns Hopkins University

    collaborator OTHER

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Dartmouth College

    collaborator OTHER

  • Dartmouth-Hitchcock Medical Center

    lead OTHER

Principal Investigators

  • Lisa A. Marsch, PhD · Dartmouth College

  • Santosh Kumar, PhD · University of Memphis

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-01
Primary Completion
2018-04-24
Completion
2018-04-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02915341 on ClinicalTrials.gov